Orion Corporation: Managers’ transactions – Juhani Kankaanpää
ORION CORPORATION
MANAGERS’ TRANSACTIONS
8 AUGUST 2025 at 9.30 EEST
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.
Orion Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Juhani Kankaanpää
Position: Other senior manager
Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 118402/4/4
____________________________________________
Transaction date: 2025-08-07
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009014377
Nature of transaction: DISPOSAL
Transaction details
(1): Volume: 81 Unit price: 64.6 EUR
(2): Volume: 52 Unit price: 64.6 EUR
(3): Volume: 14 Unit price: 64.6 EUR
(4): Volume: 100 Unit price: 64.5 EUR
(5): Volume: 58 Unit price: 64.55 EUR
(6): Volume: 197 Unit price: 64.5 EUR
(7): Volume: 104 Unit price: 64.45 EUR
(8): Volume: 101 Unit price: 64.5 EUR
(9): Volume: 41 Unit price: 64.45 EUR
(10): Volume: 45 Unit price: 64.55 EUR
(11): Volume: 100 Unit price: 64.55 EUR
(12): Volume: 102 Unit price: 64.4 EUR
(13): Volume: 44 Unit price: 64.4 EUR
(14): Volume: 77 Unit price: 64.6 EUR
(15): Volume: 20 Unit price: 64.5 EUR
(16): Volume: 94 Unit price: 64.45 EUR
(17): Volume: 9 Unit price: 64.6 EUR
(18): Volume: 102 Unit price: 64.45 EUR
(19): Volume: 94 Unit price: 64.5 EUR
(20): Volume: 100 Unit price: 64.55 EUR
(21): Volume: 240 Unit price: 64.4 EUR
(22): Volume: 214 Unit price: 64.4 EUR
(23): Volume: 58 Unit price: 64.45 EUR
(24): Volume: 339 Unit price: 64.4 EUR
(25): Volume: 94 Unit price: 64.55 EUR
(26): Volume: 100 Unit price: 64.55 EUR
(27): Volume: 101 Unit price: 64.55 EUR
(28): Volume: 117 Unit price: 64.5 EUR
(29): Volume: 42 Unit price: 64.5 EUR
(30): Volume: 91 Unit price: 64.45 EUR
(31): Volume: 58 Unit price: 64.5 EUR
(32): Volume: 107 Unit price: 64.4 EUR
(33): Volume: 124 Unit price: 64.45 EUR
(34): Volume: 108 Unit price: 64.5 EUR
(35): Volume: 58 Unit price: 64.4 EUR
(36): Volume: 100 Unit price: 64.55 EUR
(37): Volume: 101 Unit price: 64.6 EUR
(38): Volume: 200 Unit price: 64.45 EUR
(39): Volume: 101 Unit price: 64.55 EUR
(40): Volume: 112 Unit price: 64.5 EUR
Aggregated transactions (40):
Volume: 4000 Volume weighted average price: 64.48056 EUR
Orion Corporation
| Liisa Hurme President and CEO | Mikko Kemppainen General Counsel |
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Orion is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. In 2024 Orion's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicated to building well-being. Orion's A and B shares are listed on Nasdaq Helsinki.
